Fedratinib US FDA Label

  • Compound: N-tert-butyl-3-[[5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]amino]benzenesulfonamide
  • Description: N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide is a sulfonamide.
  • Brand Name:
  • Code(s): TG101348
  • Approved:
  • Kinase Class: NRY
  • Inhibitor Type: I ½B
  • Literature (PubMed): 0
  • Target(s): Janus kinase 2
  • Disease(s):

Identifiers (4)

  • International Nonproprietary Name: FEDRATINIB [INN] (Source: PubChem)
  • KEGG Drug ID: D10630 (Source: PubChem)
  • USFDA Precision ID: UNII-6L1XP550I6 (Source: PubChem)
  • US Adopted Name: Fedratinib [USAN] (Source: PubChem)

    • Sources: PubChem (4)